Carret Asset Management, LLC Novartis Ag Transaction History

Carret Asset Management, LLC

  • $911 Million
  • Q2 2025

A detailed history of Carret Asset Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Carret Asset Management, LLC holds 40,081 shares of NVS stock, worth $4.55 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
40,081
Previous 39,845 0.59%
Holding current value
$4.55 Million
Previous $4.44 Million 9.21%
% of portfolio
0.53%
Previous 0.51%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 04, 2025
BUY
$101.96 - $121.01 $24,062 - $28,558
236 Added 0.59%
40,081 $4.85 Million
Q3 2024

Oct 24, 2024
SELL
$106.13 - $120.89 $126,188 - $143,738
-1,189 Reduced 2.9%
39,845 $4.58 Million
Q2 2024

Aug 01, 2024
SELL
$92.57 - $107.37 $11,108 - $12,884
-120 Reduced 0.29%
41,034 $4.37 Million
Q1 2024

Apr 18, 2024
SELL
$95.27 - $108.47 $18,577 - $21,151
-195 Reduced 0.47%
41,154 $3.98 Million
Q4 2023

Feb 02, 2024
SELL
$92.27 - $101.54 $40,783 - $44,880
-442 Reduced 1.06%
41,349 $4.18 Million
Q3 2023

Oct 12, 2023
SELL
$94.73 - $105.13 $28,419 - $31,539
-300 Reduced 0.71%
41,791 $4.26 Million
Q2 2023

Jul 25, 2023
SELL
$92.52 - $104.91 $89,004 - $100,923
-962 Reduced 2.23%
42,091 $4.25 Million
Q1 2023

May 11, 2023
SELL
$80.03 - $92.81 $319,559 - $370,590
-3,993 Reduced 8.49%
43,053 $3.96 Million
Q4 2022

Jan 10, 2023
SELL
$75.55 - $92.52 $49,636 - $60,785
-657 Reduced 1.38%
47,046 $4.27 Million
Q3 2022

Oct 11, 2022
SELL
$74.61 - $87.26 $77,967 - $91,186
-1,045 Reduced 2.14%
47,703 $3.63 Million
Q2 2022

Aug 04, 2022
SELL
$80.52 - $93.75 $30,597 - $35,625
-380 Reduced 0.77%
48,748 $4.12 Million
Q1 2022

Apr 13, 2022
BUY
$80.11 - $90.62 $38,052 - $43,044
475 Added 0.98%
49,128 $4.31 Million
Q4 2021

Jan 10, 2022
BUY
$79.7 - $88.13 $87,670 - $96,943
1,100 Added 2.31%
48,653 $4.26 Million
Q3 2021

Oct 27, 2021
SELL
$81.78 - $95.14 $64,033 - $74,494
-783 Reduced 1.62%
47,553 $3.89 Million
Q2 2021

Jul 14, 2021
BUY
$85.24 - $94.15 $35,800 - $39,543
420 Added 0.88%
48,336 $4.41 Million
Q1 2021

Jul 14, 2021
BUY
$83.5 - $98.47 $1,670 - $1,969
20 Added 0.04%
47,916 $4.1 Million
Q4 2020

Mar 16, 2021
BUY
$78.07 - $94.43 $45,280 - $54,769
580 Added 1.23%
47,896 $4.52 Million
Q3 2020

Nov 16, 2020
BUY
$82.14 - $91.0 $4,107 - $4,550
50 Added 0.11%
47,316 $4.12 Million
Q2 2020

Aug 12, 2020
SELL
$80.93 - $91.1 $10,520 - $11,843
-130 Reduced 0.27%
47,266 $4.13 Million
Q1 2020

May 18, 2020
BUY
$70.67 - $99.01 $17,738 - $24,851
251 Added 0.53%
47,396 $3.91 Million
Q4 2019

Feb 13, 2020
BUY
$84.35 - $95.37 $8,435 - $9,537
100 Added 0.21%
47,145 $4.46 Million
Q3 2019

Nov 13, 2019
SELL
$85.54 - $94.26 $49,014 - $54,010
-573 Reduced 1.2%
47,045 $4.09 Million
Q2 2019

Aug 12, 2019
SELL
$75.4 - $92.8 $63,260 - $77,859
-839 Reduced 1.73%
47,618 $4.35 Million
Q1 2019

May 15, 2019
SELL
$75.32 - $86.15 $302,937 - $346,495
-4,022 Reduced 7.66%
48,457 $4.66 Million
Q4 2018

Feb 13, 2019
SELL
$73.66 - $82.02 $2,799 - $3,116
-38 Reduced 0.07%
52,479 $4.5 Million
Q3 2018

Nov 13, 2018
SELL
$66.94 - $77.43 $18,743 - $21,680
-280 Reduced 0.53%
52,517 $4.53 Million
Q2 2018

Aug 08, 2018
BUY
$64.91 - $73.36 $82,370 - $93,093
1,269 Added 2.46%
52,797 $3.99 Million
Q1 2018

May 14, 2018
SELL
$70.39 - $84.15 $28,156 - $33,660
-400 Reduced 0.77%
51,528 $4.17 Million
Q4 2017

Feb 13, 2018
SELL
$72.33 - $77.64 $124,407 - $133,540
-1,720 Reduced 3.21%
51,928 $4.36 Million
Q3 2017

Nov 14, 2017
SELL
$74.14 - $77.27 $65,984 - $68,770
-890 Reduced 1.63%
53,648 $4.61 Million
Q2 2017

Aug 15, 2017
BUY
N/A
54,538
54,538 $4.55 Million

Others Institutions Holding NVS

# of Institutions
1,554
Shares Held
142M
Call Options Held
1.64M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $244B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Carret Asset Management, LLC Portfolio

Follow Carret Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carret Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carret Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email